Meet Lawnae Hunter:
“I had a stroke in 2014. My journey has been similar to many, lots of hard work and I have literally tried any therapy that I thought might help me. Today I still do OT,PT AND FELDENCRAIS, all several times a week. Fortunately the local hospital has supported me with their out-patient programs,
I also co-founded a local non profit STROKE AWARENESS OREGON, with a local neurologist. SAO is dedicated to FAST and recovery education. https://strokeawarenessoregon.org/
I accidently heard about a very innovative rehab device that is still in the proto type phase of development. Our local Bend hospital agreed to take this device in their out patient clinic for use by me and other patients. Long story, but the device, AMES, combines biofeedback, mechanical vibration and movement for both legs and arms. The mechanical vibration is much different, and I believe much more effective in treating my brain than saebo, bioness or others that use e-stim technology.
I used the device on both my leg and arm and as a result my gait greatly improved and for the first time in 6 years I could navigate full flights of stairs. I must admit the first time I was able to go to the downstairs part of my house and back up I just cried! I had not seen my downstairs in 6 years. I credit the AMES robotic device with this recovery. I am not a part of the iotech-AMES company in any way but you might call me their cheerleader since I am so passionate about recovery for ‘stroke warriors.”
Clinicians have been treating impairments due to stroke, spinal cord injuries and other neuromuscular traumatic events the same way, getting the same disappointing results for over 20 years.
Finally Robotic innovation for well over 100 million patients world wide.
iotech improves the lives of, and gives hope to, people with impaired movement of the upper and lower extremities, their family members, and their caregivers by providing leading edge devices for Impairment Oriented Training (IOT).
Hundreds of patients who had lost all hope of ever using their arms, legs, hands and/or feet have gratefully regained functional movement of their extremities using iotech’s innovative device –AMES™
Spasticity is a condition in which muscles stiffen or tighten, preventing normal fluid movement. The muscles remain contracted and resist being stretched, thus affecting movement , speech and gait.
Impairments due to strokes, spinal cord injuries and other neurological/muscular traumatic events:
AMES™ (Assisted Movement with Enhanced Sensation) technology is iotech’s first commercially ready market offering. AMES is a patented, FDA 510(k)-cleared, robotic rehabilitative exercise technology that has been clinically proven in over 400 patients to improve movement and functionality of patients’ arms, wrists, hands, fingers, legs, ankles and toes. AMES technology has been proven effective in restoring mobility, strength, range of motion and sensation, even when other protocols have failed. The market for robotic rehabilitation devices exceeds $5B.
The Food and Drug Administration has approved AMES effectiveness with the coveted (and expensive) 510k certification.
There have already been in depth clinical studies. For example:
In a recent multi-center, crossover, double-blind study, AMES showed improved impairments in stroke patients. This study is pending publication in a highly respected peer-reviewed medical journal. Results from other studies showing AMES technology to be safe and effective have been published in four prestigious, peer-reviewed medical journals, including Neurorehabilitation and Neural Repair, Archives of Physical Medicine and Rehabilitation, Journal of Neurological Rehabilitation, and Journal of Neurological Disorders and Stroke. In these studies, AMES technology:
– significantly reduced impairment and improved function in people who were severely affected by strokes and spinal cord injuries;
– in individuals with incomplete spinal cord injury (>1-year post injury), AMES therapy significantly reduced impairment and improved functional movement in the upper limbs. In half of the participants, sensation returned to fingers within 2-3 treatments;
– AMES therapy reduced spasticity and long-term pain in a participant with incomplete spinal cord injury to the point where the participant was able to stop taking pain medication.
Also, in two additional lower limb studies (one in press, one in review, the results showed improved lower limb movement and gait in ~80% of participants with moderate to severe impairment).
In its 510(k)-decision letter concerning AMES technology, the FDA states that AMES technology “uses assisted movement combined with muscle vibration to measure, evaluate, exercise, re-educate and strengthen muscles, for increased range of motion and for muscle relaxation”.
AMES devices have qualified for Medicare, Medicaid and commercial insurance reimbursement (CPT codes 97110, 97112, 97140, 97161, 97162, 97163, 97164, 97165, 97166, 97167, 97168, 97530, 97750 and 90901).
iotech is re-configuring its investigative device into a pipeline of commercial products and has assembled a world-class team to establish iotech as the industry authority in Impairment Oriented Training for the global robotic rehabilitation market, which is projected to reach $6.4 billion by 2025.[1]
Click the button below for a selection of clinical papers for reference.